CLINICAL ROLE -
Epitnezumab Shows Promise Treating Chronic Migraines
Treatment with eptinezumab resulted in an average reduction of 8.2 monthly migraine days.
Read More
Need to Evaluate Pain Management in Elderly Population Grows
Challenges perist in the use of opioids, anti-inflammatories, and agents to treat pain in the elderly.
Pediatric Multiple Sclerosis Drug Gets FDA Breakthrough Designation
Fingolimod was previously approved to treat relapsing multiple sclerosis as a once-daily disease-modifying therapy.
Gene Transfer Therapy Gets FDA Fast Track
RT-100 AC6 treats patients with heart failure with reduced ejection fraction.
Alzheimer's Rates Projected to Double Over Next 20 Years
By 2060, 15 million people in the United States will be living with mild cognitive impairment due to Alzheimer’s disease.
Synthetic Cannabis Treatment Improves Obstructive Sleep Apnea
Synthetic cannabis-like therapy dronabinol associated with a lower overall apnea/hypopnea index compared with placebo.
Managing Stress in Younger Cancer Patients
A cancer diagnosis in young patients can cause post-traumatic stress disorder that can persist long afterwards.
Healthier Lifestyle Can Improve Long-Term Type 2 Diabetes Risk
Patients who engage in lifestyle changes can effectively prevent or at least delay a lifelong, chronic disease.
FDA Approves New Hepatitis Therapy
Heplisav-B is the only 2-dose hepatitis B vaccine recombinant approved in the United States.
Inflammatory Bowel Disease Drug Safety Profile Consistent in Real-World Use
Vedolizumab (Entyvio) remains consistent in its safety profile in study of real-world data on ulcerative colitis and Crohn's disease.
Golimumab Approved for Psoriatic Arthritis, Ankylosing Spondylitis
Two supplemental biologics license applications granted to golimumab to treat adults with psoriatic arthritis and adults with active ankylosing spondylitis.
Psoriatic Arthritis, Ankylosing Spondylitis Treatment Gets Approval
Golimumab is the only fully-human anti-tumor necrosis factor (TNF) alpha therapy that is administered with a 30-minute infusion.
Triple-Combination Therapy Under Evaluation for COPD
Trial to analyze which commonly prescribed therapies can reduce exacerbations in patients with chronic obstructive pulmonary disease.
FDA Committee Supports Approval of Once-Weekly Diabetes Drug
Once-weekly injection of semaglutide recommended for approval for improved glycemic control in adults with type 2 diabetes.
Merck Reaches Deal to Develop Diabetic Macular Edema Drug
Merck has entered an agreement to develop KalVista Pharmaceuticals’ investigational DME drug.
Osteoarthritis Knee Pain Drug Gets FDA Approval
Zilretta is the first non-opioid, extended-release, intra-articular injection for the treatment of osteoarthritis knee pain.
Concomitant Treatment With Gabapentin Increases Risk of Opioid Overdose
Gabapentin and opioids are often prescribed together to treat chronic pain and both have shown a potentially fatal risk of breathing suppression.
FDA OKs Osteoarthritis Knee Pain Drug
It is currently the first and only extended-release, intra-articular injection available for OA.
Looming Biosimilars May Impact Top Selling Rheumatoid Arthritis Drug
Spending for adalimumab has tripled from 2012 from $4.5 billion.
ADHD Drug Achieves Endpoints in Phase 3 Trial
Guanfacine (Intuniv) for attention-deficit hyperactivity disorder (ADHD) shows marked clinical improvement in global functioning.
FDA Committee Requests More Data on Duchenne Muscular Dystrophy Drug
FDA advisory committee votes the data was inconclusive on ataluren (translarna), a first-in-class oral treatment for Duchenne muscular dystrophy.
FDA, Interpol Target Illegal Online Pharmacies
Hundreds of websites selling unapproved drugs, including opioids, antibiotics, and injectable epinephrine products.
MDMA Treatment Granted Breakthrough Designation for Post-Traumatic Stress Disorder
Psychedelic-assisted MDMA psychotherapy will be evaluated in Phase 3 trials for PTSD.
Direct-acting Antivirals Help Non-specialists Effectively Manage Hepatitis C Virus
An estimated 2.7 million Americans have hepatitis C, too many for specialists to be the sole provider of anti-HCV therapy.
PCSK9 Inhibitor Gets Priority Review as Cardiovascular Risk Treatment
Repatha combined with statin therapy may reduce cardiovascular events.
Diabetic Retinopathy Associated With Significant Visual-Function Issues
Severe diabetic retinopathy has a more detrimental effect on visual function than lesser forms of the disease.